AI‐Driven Integration of Minority Stress, Gender‐Affirming Hormone Therapy, and Epigenetic Aging in Alzheimer's Disease Progression in Transgender Individuals

Abstract

Background: The intersection of minority stress, epigenetic aging, and Alzheimer's disease (AD) progression is a critical yet underexplored research area, particularly among transgender individuals undergoing gender‐affirming hormone therapy (GAHT).